{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:00:31Z","timestamp":1784988031088,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL176685"],"award-info":[{"award-number":["HL176685"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL153406"],"award-info":[{"award-number":["HL153406"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008136","name":"Case Western Reserve University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.yjmcc.2026.06.001","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:36:39Z","timestamp":1780673799000},"page":"40-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Histone Deacetylase 7 protects against pathologic cardiac hypertrophy"],"prefix":"10.1016","volume":"217","author":[{"given":"Jin","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie M.","family":"Hand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yjmcc.2026.06.001_bb0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3949\/ccjm.85a.17076","article-title":"Hypertrophic cardiomyopathy: a complex disease","volume":"85","author":"Young","year":"2018","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2023.04.005","article-title":"How common is hypertrophic cardiomyopathy... Really?: disease prevalence revisited 27 years after CARDIA","volume":"382","author":"Massera","year":"2023","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.yjmcc.2026.06.001_bb0015","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1080\/14656566.2023.2219840","article-title":"Current and emerging pharmacotherapy for the management of hypertrophic cardiomyopathy","volume":"24","author":"Rosenzveig","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"issue":"8","key":"10.1016\/j.yjmcc.2026.06.001_bb0020","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacbts.2019.05.011","article-title":"Epigenetics in cardiac hypertrophy and heart failure","volume":"4","author":"Liu","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0025","doi-asserted-by":"crossref","first-page":"1405569","DOI":"10.3389\/fphys.2024.1405569","article-title":"Targeting histone deacetylase in cardiac diseases","volume":"15","author":"Lu","year":"2024","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2026.06.001_bb0030","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s42003-018-0214-4","article-title":"Structural and chemical biology of deacetylases for carbohydrates, proteins, small molecules and histones","volume":"1","author":"Burger","year":"2018","journal-title":"Commun Biol"},{"issue":"9","key":"10.1016\/j.yjmcc.2026.06.001_bb0040","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/j.1582-4934.2011.01321.x","article-title":"Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis","volume":"15","author":"Clocchiatti","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2021.08.007","article-title":"Post-translational modifications talk and crosstalk to class IIa histone deacetylases","volume":"162","author":"Guttzeit","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.yjmcc.2026.06.001_bb0050","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","article-title":"Three proteins define a class of human histone deacetylases related to yeast Hda1p","volume":"96","author":"Grozinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.yjmcc.2026.06.001_bb0055","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1073\/pnas.97.3.1056","article-title":"Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5","volume":"97","author":"Zhou","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.yjmcc.2026.06.001_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1101\/gad.14.1.55","article-title":"Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression","volume":"14","author":"Kao","year":"2000","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.yjmcc.2026.06.001_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2006.05.040","article-title":"Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10","volume":"126","author":"Chang","year":"2006","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.yjmcc.2026.06.001_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjae044","article-title":"HDAC7 promotes cardiomyocyte proliferation by suppressing myocyte enhancer factor 2","volume":"16","author":"Jang","year":"2024","journal-title":"J. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.yjmcc.2026.06.001_bb0075","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2004.10.024","article-title":"Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis","volume":"119","author":"Vega","year":"2004","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.yjmcc.2026.06.001_bb0080","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","article-title":"Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development","volume":"24","author":"Chang","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.931475","article-title":"Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors","volume":"9","author":"Han","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2026.06.001_bb0090","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1113\/jphysiol.2014.282442","article-title":"Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms","volume":"593","author":"Weeks","year":"2015","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2026.06.001_bb0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"Zhang","year":"2002","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.yjmcc.2026.06.001_bb0100","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI61084","article-title":"HDAC4 controls histone methylation in response to elevated cardiac load","volume":"123","author":"Hohl","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.yjmcc.2026.06.001_bb0105","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1073\/pnas.0337639100","article-title":"Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5","volume":"100","author":"Czubryt","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.yjmcc.2026.06.001_bb0110","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1152\/japplphysiol.00006.2018","article-title":"Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium","volume":"125","author":"Zhang","year":"2018","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0115","article-title":"Transverse aortic constriction in mice","volume":"38","author":"Almeida","year":"2010","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.yjmcc.2026.06.001_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.105963","article-title":"Exosomes mediated fibrogenesis in dilated cardiomyopathy through a MicroRNA pathway","volume":"26","author":"Fu","year":"2023","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.yjmcc.2026.06.001_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCRESAHA.121.320324","article-title":"p53 regulates the extent of fibroblast proliferation and fibrosis in left ventricle pressure overload","volume":"133","author":"Liu","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0130","article-title":"Innate immune cells in pressure overload-induced cardiac hypertrophy and remodeling","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109869","article-title":"Diverse origins and activation of fibroblasts in cardiac fibrosis","volume":"78","author":"Aujla","year":"2021","journal-title":"Cell. Signal."},{"issue":"26","key":"10.1016\/j.yjmcc.2026.06.001_bb0140","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1073\/pnas.0603615103","article-title":"Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha","volume":"103","author":"Arany","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.yjmcc.2026.06.001_bb0145","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI9056","article-title":"Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth","volume":"105","author":"Barger","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.yjmcc.2026.06.001_bb0150","doi-asserted-by":"crossref","first-page":"H1585","DOI":"10.1152\/ajpheart.00599.2009","article-title":"A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload","volume":"297","author":"Chess","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2026.06.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101560","article-title":"A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming","volume":"3","author":"Lyra-Leite","year":"2022","journal-title":"STAR Protoc"},{"issue":"10","key":"10.1016\/j.yjmcc.2026.06.001_bb0160","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.bbamcr.2010.06.008","article-title":"Histone deacetylase 7 (HDAC7) regulates myocyte migration and differentiation","volume":"1803","author":"Gao","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"20","key":"10.1016\/j.yjmcc.2026.06.001_bb0165","doi-asserted-by":"crossref","first-page":"17007","DOI":"10.1074\/jbc.M101508200","article-title":"A dynamic role for HDAC7 in MEF2-mediated muscle differentiation","volume":"276","author":"Dressel","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.yjmcc.2026.06.001_bb0170","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bbadis.2013.07.023","article-title":"Regulation of fetal gene expression in heart failure","volume":"1832","author":"Dirkx","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.yjmcc.2026.06.001_bb0175","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yjmcc.2019.04.003","article-title":"Histone deacetylases in cardiovascular and metabolic diseases","volume":"130","author":"Bagchi","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2026.06.001_bb0185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2022.01.002","article-title":"MEF2 in cardiac hypertrophy in response to hypertension","volume":"33","author":"Cornwell","year":"2023","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.yjmcc.2026.06.001_bb0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/rp.59.1.105","article-title":"Balancing contractility and energy production: the role of myocyte enhancer factor 2 (MEF2) in cardiac hypertrophy","volume":"59","author":"Czubryt","year":"2004","journal-title":"Recent Prog. Horm. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2026.06.001_bb0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1172\/JCI33255","article-title":"The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice","volume":"118","author":"Kim","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.yjmcc.2026.06.001_bb0200","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ydbio.2018.12.002","article-title":"Cardiovascular development and survival require Mef2c function in the myocardial but not the endothelial lineage","volume":"445","author":"Materna","year":"2019","journal-title":"Dev. Biol."},{"issue":"12","key":"10.1016\/j.yjmcc.2026.06.001_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008472","article-title":"MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR\/S6K pathway in mice","volume":"4","author":"Pereira","year":"2009","journal-title":"PloS One"},{"issue":"51","key":"10.1016\/j.yjmcc.2026.06.001_bb0210","doi-asserted-by":"crossref","first-page":"20975","DOI":"10.1074\/jbc.M117.806422","article-title":"The transcription factor MEF2A fine-tunes gene expression in the atrial and ventricular chambers of the adult heart","volume":"292","author":"Medrano","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yjmcc.2026.06.001_bb0215","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1074\/mcp.O114.046565","article-title":"Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease","volume":"14","author":"Mathias","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"issue":"6","key":"10.1016\/j.yjmcc.2026.06.001_bb0220","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1172\/JCI133753","article-title":"Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling","volume":"130","author":"Hsu","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.yjmcc.2026.06.001_bb0225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacbts.2019.02.006","article-title":"Fibroblasts in the infarcted, remodeling, and failing heart","volume":"4","author":"Humeres","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"21","key":"10.1016\/j.yjmcc.2026.06.001_bb0230","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","article-title":"Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy","volume":"141","author":"Ren","year":"2020","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.yjmcc.2026.06.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93187","article-title":"Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction","volume":"2","author":"Shimizu","year":"2017","journal-title":"JCI Insight"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282826000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282826000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:01:38Z","timestamp":1784984498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282826000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":47,"alternative-id":["S0022282826000854"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2026.06.001","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone Deacetylase 7 protects against pathologic cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2026.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}